The store will not work correctly when cookies are disabled.
N-[4-(Diethylamino)phenyl]-5-methyl-3-(thiophen-3-yl)isoxazole-4-carboxamide
ID: ALA4537362
PubChem CID: 134367369
Max Phase: Preclinical
Molecular Formula: C19H21N3O2S
Molecular Weight: 355.46
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCN(CC)c1ccc(NC(=O)c2c(-c3ccsc3)noc2C)cc1
Standard InChI: InChI=1S/C19H21N3O2S/c1-4-22(5-2)16-8-6-15(7-9-16)20-19(23)17-13(3)24-21-18(17)14-10-11-25-12-14/h6-12H,4-5H2,1-3H3,(H,20,23)
Standard InChI Key: FAOOXGFJELDQNN-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
3.8854 -12.3387 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8792 -13.1600 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.6581 -13.4202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1493 -12.7608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6680 -12.0944 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8795 -11.3051 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3655 -10.6704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8104 -9.9853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5993 -10.1967 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
5.6420 -11.0124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9665 -12.7669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3804 -12.0623 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.3698 -13.4776 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.1870 -13.4837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5884 -14.1965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4048 -14.2029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8195 -13.4978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4118 -12.7847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5967 -12.7817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6367 -13.5027 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.0409 -14.2129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8581 -14.2179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0496 -12.7975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8667 -12.8025 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9028 -14.1999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 1 2 0
6 5 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 1 0
10 6 2 0
4 11 1 0
11 12 2 0
11 13 1 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
17 20 1 0
20 21 1 0
21 22 1 0
20 23 1 0
23 24 1 0
3 25 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 355.46 | Molecular Weight (Monoisotopic): 355.1354 | AlogP: 4.81 | #Rotatable Bonds: 6 |
Polar Surface Area: 58.37 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.87 | CX Basic pKa: 5.42 | CX LogP: 4.26 | CX LogD: 4.26 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.69 | Np Likeness Score: -2.40 |
References
1. Jumppanen M, Kinnunen SM, Välimäki MJ, Talman V, Auno S, Bruun T, Boije Af Gennäs G, Xhaard H, Aumüller IB, Ruskoaho H, Yli-Kauhaluoma J.. (2019) Synthesis, Identification, and Structure-Activity Relationship Analysis of GATA4 and NKX2-5 Protein-Protein Interaction Modulators., 62 (17): [PMID:31431011] [10.1021/acs.jmedchem.9b01086] |